These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24202110)

  • 1. [Neuropathic pain associated with Nav1.7 mutations: clinical picture and treatment].
    Doppler K; Sommer C
    Nervenarzt; 2013 Dec; 84(12):1428-35. PubMed ID: 24202110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral congenital corneal anesthesia in a patient with SCN9A mutation, confirmed primary erythromelalgia, and paroxysmal extreme pain disorder.
    Kim DT; Rossignol E; Najem K; Ospina LH
    J AAPOS; 2015 Oct; 19(5):478-9. PubMed ID: 26486037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pain and analgesia : Mutations of voltage-gated sodium channels].
    Eberhardt MJ; Leffler A
    Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
    Emery EC; Habib AM; Cox JJ; Nicholas AK; Gribble FM; Woods CG; Reimann F
    J Neurosci; 2015 May; 35(20):7674-81. PubMed ID: 25995458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited pain: sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation.
    Eberhardt M; Nakajima J; Klinger AB; Neacsu C; Hühne K; O'Reilly AO; Kist AM; Lampe AK; Fischer K; Gibson J; Nau C; Winterpacht A; Lampert A
    J Biol Chem; 2014 Jan; 289(4):1971-80. PubMed ID: 24311784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary erythromelalgia: a review.
    Tang Z; Chen Z; Tang B; Jiang H
    Orphanet J Rare Dis; 2015 Sep; 10():127. PubMed ID: 26419464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythromelalgia: skin redness and pain].
    Dusch M; Schmelz M
    Schmerz; 2019 Oct; 33(5):475-490. PubMed ID: 31485751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Painful Na-channelopathies: an expanding universe.
    Waxman SG
    Trends Mol Med; 2013 Jul; 19(7):406-9. PubMed ID: 23664154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic, electrophysiological, and pathological studies on patients with SCN9A-related pain disorders.
    Yuan JH; Cheng X; Matsuura E; Higuchi Y; Ando M; Hashiguchi A; Yoshimura A; Nakachi R; Mine J; Taketani T; Maeda K; Kawakami S; Kira R; Tanaka S; Kanai K; Dib-Hajj F; Dib-Hajj SD; Waxman SG; Takashima H
    J Peripher Nerv Syst; 2023 Dec; 28(4):597-607. PubMed ID: 37555797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
    Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M
    Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile.
    McDonnell A; Schulman B; Ali Z; Dib-Hajj SD; Brock F; Cobain S; Mainka T; Vollert J; Tarabar S; Waxman SG
    Brain; 2016 Apr; 139(Pt 4):1052-65. PubMed ID: 26920677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series.
    Arthur L; Keen K; Verriotis M; Peters J; Kelly A; Howard RF; Dib-Hajj SD; Waxman SG; Walker SM
    J Pediatr; 2019 Mar; 206():217-224.e9. PubMed ID: 30416015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network topology of NaV1.7 mutations in sodium channel-related painful disorders.
    Kapetis D; Sassone J; Yang Y; Galbardi B; Xenakis MN; Westra RL; Szklarczyk R; Lindsey P; Faber CG; Gerrits M; Merkies IS; Dib-Hajj SD; Mantegazza M; Waxman SG; Lauria G;
    BMC Syst Biol; 2017 Feb; 11(1):28. PubMed ID: 28235406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia.
    Klein CJ; Wu Y; Kilfoyle DH; Sandroni P; Davis MD; Gavrilova RH; Low PA; Dyck PJ
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):386-91. PubMed ID: 23129781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous enhancement of resurgent Na
    Huang CW; Lai HJ; Huang PY; Lee MJ; Kuo CC
    Sci Rep; 2019 Aug; 9(1):12251. PubMed ID: 31439884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium channel slow inactivation interferes with open channel block.
    Hampl M; Eberhardt E; O'Reilly AO; Lampert A
    Sci Rep; 2016 May; 6():25974. PubMed ID: 27174182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.
    Wu B; Zhang Y; Tang H; Yang M; Long H; Shi G; Tang J; Shi X
    Curr Mol Med; 2017; 17(6):450-457. PubMed ID: 28990532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromelalgia caused by the missense mutation p.Arg220Pro in an alternatively spliced exon of SCN9A (NaV1.7).
    Deuis JR; Kumble S; Keramidas A; Ragnarsson L; Simons C; Pais L; White SM; Vetter I
    Hum Mol Genet; 2024 Jan; 33(2):103-109. PubMed ID: 37721535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation.
    Watabe D; Tominaga M; Toyama S; Takamori K; Nakano H; Amano H
    J Dermatol; 2023 Jul; 50(7):938-941. PubMed ID: 36815391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the treatment options for paroxysmal extreme pain disorder?
    Suter MR
    Pain Manag; 2015; 5(4):229-32. PubMed ID: 26059255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.